Non-Oncology Precision Medicine and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Non-Oncology Precision Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-Oncology Precision Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-Oncology Precision Medicine Overall Market Size
2.1 Global Non-Oncology Precision Medicine Market Size: 2021 VS 2028
2.2 Global Non-Oncology Precision Medicine Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Non-Oncology Precision Medicine Players in Global Market
3.2 Top Global Non-Oncology Precision Medicine Companies Ranked by Revenue
3.3 Global Non-Oncology Precision Medicine Revenue by Companies
3.4 Top 3 and Top 5 Non-Oncology Precision Medicine Companies in Global Market, by Revenue in 2021
3.5 Global Companies Non-Oncology Precision Medicine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Non-Oncology Precision Medicine Players in Global Market
3.6.1 List of Global Tier 1 Non-Oncology Precision Medicine Companies
3.6.2 List of Global Tier 2 and Tier 3 Non-Oncology Precision Medicine Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Non-Oncology Precision Medicine Market Size Markets, 2021 & 2028
4.1.2 Applied Sciences
4.1.3 Precision Diagnostics
4.1.4 Digital Health and Information Technology
4.1.5 Precision Therapeutics
4.2 By Type - Global Non-Oncology Precision Medicine Revenue & Forecasts
4.2.1 By Type - Global Non-Oncology Precision Medicine Revenue, 2017-2022
4.2.2 By Type - Global Non-Oncology Precision Medicine Revenue, 2023-2028
4.2.3 By Type - Global Non-Oncology Precision Medicine Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Non-Oncology Precision Medicine Market Size, 2021 & 2028
5.1.2 Infectious Diseases
5.1.3 Neurology
5.1.4 Cardiovascular
5.1.5 Lifestyle and Endocrinology
5.1.6 Gastroenterology
5.1.7 Others
5.2 By Application - Global Non-Oncology Precision Medicine Revenue & Forecasts
5.2.1 By Application - Global Non-Oncology Precision Medicine Revenue, 2017-2022
5.2.2 By Application - Global Non-Oncology Precision Medicine Revenue, 2023-2028
5.2.3 By Application - Global Non-Oncology Precision Medicine Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Non-Oncology Precision Medicine Market Size, 2021 & 2028
6.2 By Region - Global Non-Oncology Precision Medicine Revenue & Forecasts
6.2.1 By Region - Global Non-Oncology Precision Medicine Revenue, 2017-2022
6.2.2 By Region - Global Non-Oncology Precision Medicine Revenue, 2023-2028
6.2.3 By Region - Global Non-Oncology Precision Medicine Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Non-Oncology Precision Medicine Revenue, 2017-2028
6.3.2 US Non-Oncology Precision Medicine Market Size, 2017-2028
6.3.3 Canada Non-Oncology Precision Medicine Market Size, 2017-2028
6.3.4 Mexico Non-Oncology Precision Medicine Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Non-Oncology Precision Medicine Revenue, 2017-2028
6.4.2 Germany Non-Oncology Precision Medicine Market Size, 2017-2028
6.4.3 France Non-Oncology Precision Medicine Market Size, 2017-2028
6.4.4 U.K. Non-Oncology Precision Medicine Market Size, 2017-2028
6.4.5 Italy Non-Oncology Precision Medicine Market Size, 2017-2028
6.4.6 Russia Non-Oncology Precision Medicine Market Size, 2017-2028
6.4.7 Nordic Countries Non-Oncology Precision Medicine Market Size, 2017-2028
6.4.8 Benelux Non-Oncology Precision Medicine Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Non-Oncology Precision Medicine Revenue, 2017-2028
6.5.2 China Non-Oncology Precision Medicine Market Size, 2017-2028
6.5.3 Japan Non-Oncology Precision Medicine Market Size, 2017-2028
6.5.4 South Korea Non-Oncology Precision Medicine Market Size, 2017-2028
6.5.5 Southeast Asia Non-Oncology Precision Medicine Market Size, 2017-2028
6.5.6 India Non-Oncology Precision Medicine Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Non-Oncology Precision Medicine Revenue, 2017-2028
6.6.2 Brazil Non-Oncology Precision Medicine Market Size, 2017-2028
6.6.3 Argentina Non-Oncology Precision Medicine Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Non-Oncology Precision Medicine Revenue, 2017-2028
6.7.2 Turkey Non-Oncology Precision Medicine Market Size, 2017-2028
6.7.3 Israel Non-Oncology Precision Medicine Market Size, 2017-2028
6.7.4 Saudi Arabia Non-Oncology Precision Medicine Market Size, 2017-2028
6.7.5 UAE Non-Oncology Precision Medicine Market Size, 2017-2028
7 Players Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Corporate Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Non-Oncology Precision Medicine Major Product Offerings
7.1.4 Abbott Laboratories Non-Oncology Precision Medicine Revenue in Global Market (2017-2022)
7.1.5 Abbott Laboratories Key News
7.2 Agilent Technologies, Inc.
7.2.1 Agilent Technologies, Inc. Corporate Summary
7.2.2 Agilent Technologies, Inc. Business Overview
7.2.3 Agilent Technologies, Inc. Non-Oncology Precision Medicine Major Product Offerings
7.2.4 Agilent Technologies, Inc. Non-Oncology Precision Medicine Revenue in Global Market (2017-2022)
7.2.5 Agilent Technologies, Inc. Key News
7.3 Asuragen, Inc.
7.3.1 Asuragen, Inc. Corporate Summary
7.3.2 Asuragen, Inc. Business Overview
7.3.3 Asuragen, Inc. Non-Oncology Precision Medicine Major Product Offerings
7.3.4 Asuragen, Inc. Non-Oncology Precision Medicine Revenue in Global Market (2017-2022)
7.3.5 Asuragen, Inc. Key News
7.4 Almac Group
7.4.1 Almac Group Corporate Summary
7.4.2 Almac Group Business Overview
7.4.3 Almac Group Non-Oncology Precision Medicine Major Product Offerings
7.4.4 Almac Group Non-Oncology Precision Medicine Revenue in Global Market (2017-2022)
7.4.5 Almac Group Key News
7.5 AstraZeneca PLC
7.5.1 AstraZeneca PLC Corporate Summary
7.5.2 AstraZeneca PLC Business Overview
7.5.3 AstraZeneca PLC Non-Oncology Precision Medicine Major Product Offerings
7.5.4 AstraZeneca PLC Non-Oncology Precision Medicine Revenue in Global Market (2017-2022)
7.5.5 AstraZeneca PLC Key News
7.6 Bristol Myers Squibb
7.6.1 Bristol Myers Squibb Corporate Summary
7.6.2 Bristol Myers Squibb Business Overview
7.6.3 Bristol Myers Squibb Non-Oncology Precision Medicine Major Product Offerings
7.6.4 Bristol Myers Squibb Non-Oncology Precision Medicine Revenue in Global Market (2017-2022)
7.6.5 Bristol Myers Squibb Key News
7.7 bioM?rieux SA.
7.7.1 bioM?rieux SA. Corporate Summary
7.7.2 bioM?rieux SA. Business Overview
7.7.3 bioM?rieux SA. Non-Oncology Precision Medicine Major Product Offerings
7.7.4 bioM?rieux SA. Non-Oncology Precision Medicine Revenue in Global Market (2017-2022)
7.7.5 bioM?rieux SA. Key News
7.8 BGI
7.8.1 BGI Corporate Summary
7.8.2 BGI Business Overview
7.8.3 BGI Non-Oncology Precision Medicine Major Product Offerings
7.8.4 BGI Non-Oncology Precision Medicine Revenue in Global Market (2017-2022)
7.8.5 BGI Key News
7.9 Danaher Corp.
7.9.1 Danaher Corp. Corporate Summary
7.9.2 Danaher Corp. Business Overview
7.9.3 Danaher Corp. Non-Oncology Precision Medicine Major Product Offerings
7.9.4 Danaher Corp. Non-Oncology Precision Medicine Revenue in Global Market (2017-2022)
7.9.5 Danaher Corp. Key News
7.10 Illumina, Inc.
7.10.1 Illumina, Inc. Corporate Summary
7.10.2 Illumina, Inc. Business Overview
7.10.3 Illumina, Inc. Non-Oncology Precision Medicine Major Product Offerings
7.10.4 Illumina, Inc. Non-Oncology Precision Medicine Revenue in Global Market (2017-2022)
7.10.5 Illumina, Inc. Key News
7.11 Invitae Corporation
7.11.1 Invitae Corporation Corporate Summary
7.11.2 Invitae Corporation Business Overview
7.11.3 Invitae Corporation Non-Oncology Precision Medicine Major Product Offerings
7.11.4 Invitae Corporation Non-Oncology Precision Medicine Revenue in Global Market (2017-2022)
7.11.5 Invitae Corporation Key News
7.12 Opko Health, Inc.
7.12.1 Opko Health, Inc. Corporate Summary
7.12.2 Opko Health, Inc. Business Overview
7.12.3 Opko Health, Inc. Non-Oncology Precision Medicine Major Product Offerings
7.12.4 Opko Health, Inc. Non-Oncology Precision Medicine Revenue in Global Market (2017-2022)
7.12.5 Opko Health, Inc. Key News
7.13 Teva Pharmaceutical Industries Ltd.
7.13.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
7.13.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.13.3 Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Major Product Offerings
7.13.4 Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Revenue in Global Market (2017-2022)
7.13.5 Teva Pharmaceutical Industries Ltd. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Non-Oncology Precision Medicine Market Opportunities & Trends in Global Market
Table 2. Non-Oncology Precision Medicine Market Drivers in Global Market
Table 3. Non-Oncology Precision Medicine Market Restraints in Global Market
Table 4. Key Players of Non-Oncology Precision Medicine in Global Market
Table 5. Top Non-Oncology Precision Medicine Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Non-Oncology Precision Medicine Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Non-Oncology Precision Medicine Revenue Share by Companies, 2017-2022
Table 8. Global Companies Non-Oncology Precision Medicine Product Type
Table 9. List of Global Tier 1 Non-Oncology Precision Medicine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non-Oncology Precision Medicine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Non-Oncology Precision Medicine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Non-Oncology Precision Medicine Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Non-Oncology Precision Medicine Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Non-Oncology Precision Medicine Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Non-Oncology Precision Medicine Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Non-Oncology Precision Medicine Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Non-Oncology Precision Medicine Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Non-Oncology Precision Medicine Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Non-Oncology Precision Medicine Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Non-Oncology Precision Medicine Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Non-Oncology Precision Medicine Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Non-Oncology Precision Medicine Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Non-Oncology Precision Medicine Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Non-Oncology Precision Medicine Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Non-Oncology Precision Medicine Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Non-Oncology Precision Medicine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Non-Oncology Precision Medicine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Non-Oncology Precision Medicine Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Non-Oncology Precision Medicine Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Non-Oncology Precision Medicine Product Offerings
Table 32. Abbott Laboratories Non-Oncology Precision Medicine Revenue (US$, Mn), (2017-2022)
Table 33. Agilent Technologies, Inc. Corporate Summary
Table 34. Agilent Technologies, Inc. Non-Oncology Precision Medicine Product Offerings
Table 35. Agilent Technologies, Inc. Non-Oncology Precision Medicine Revenue (US$, Mn), (2017-2022)
Table 36. Asuragen, Inc. Corporate Summary
Table 37. Asuragen, Inc. Non-Oncology Precision Medicine Product Offerings
Table 38. Asuragen, Inc. Non-Oncology Precision Medicine Revenue (US$, Mn), (2017-2022)
Table 39. Almac Group Corporate Summary
Table 40. Almac Group Non-Oncology Precision Medicine Product Offerings
Table 41. Almac Group Non-Oncology Precision Medicine Revenue (US$, Mn), (2017-2022)
Table 42. AstraZeneca PLC Corporate Summary
Table 43. AstraZeneca PLC Non-Oncology Precision Medicine Product Offerings
Table 44. AstraZeneca PLC Non-Oncology Precision Medicine Revenue (US$, Mn), (2017-2022)
Table 45. Bristol Myers Squibb Corporate Summary
Table 46. Bristol Myers Squibb Non-Oncology Precision Medicine Product Offerings
Table 47. Bristol Myers Squibb Non-Oncology Precision Medicine Revenue (US$, Mn), (2017-2022)
Table 48. bioM?rieux SA. Corporate Summary
Table 49. bioM?rieux SA. Non-Oncology Precision Medicine Product Offerings
Table 50. bioM?rieux SA. Non-Oncology Precision Medicine Revenue (US$, Mn), (2017-2022)
Table 51. BGI Corporate Summary
Table 52. BGI Non-Oncology Precision Medicine Product Offerings
Table 53. BGI Non-Oncology Precision Medicine Revenue (US$, Mn), (2017-2022)
Table 54. Danaher Corp. Corporate Summary
Table 55. Danaher Corp. Non-Oncology Precision Medicine Product Offerings
Table 56. Danaher Corp. Non-Oncology Precision Medicine Revenue (US$, Mn), (2017-2022)
Table 57. Illumina, Inc. Corporate Summary
Table 58. Illumina, Inc. Non-Oncology Precision Medicine Product Offerings
Table 59. Illumina, Inc. Non-Oncology Precision Medicine Revenue (US$, Mn), (2017-2022)
Table 60. Invitae Corporation Corporate Summary
Table 61. Invitae Corporation Non-Oncology Precision Medicine Product Offerings
Table 62. Invitae Corporation Non-Oncology Precision Medicine Revenue (US$, Mn), (2017-2022)
Table 63. Opko Health, Inc. Corporate Summary
Table 64. Opko Health, Inc. Non-Oncology Precision Medicine Product Offerings
Table 65. Opko Health, Inc. Non-Oncology Precision Medicine Revenue (US$, Mn), (2017-2022)
Table 66. Teva Pharmaceutical Industries Ltd. Corporate Summary
Table 67. Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Product Offerings
Table 68. Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Non-Oncology Precision Medicine Segment by Type in 2021
Figure 2. Non-Oncology Precision Medicine Segment by Application in 2021
Figure 3. Global Non-Oncology Precision Medicine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Non-Oncology Precision Medicine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Non-Oncology Precision Medicine Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Non-Oncology Precision Medicine Revenue in 2021
Figure 8. By Type - Global Non-Oncology Precision Medicine Revenue Market Share, 2017-2028
Figure 9. By Application - Global Non-Oncology Precision Medicine Revenue Market Share, 2017-2028
Figure 10. By Region - Global Non-Oncology Precision Medicine Revenue Market Share, 2017-2028
Figure 11. By Country - North America Non-Oncology Precision Medicine Revenue Market Share, 2017-2028
Figure 12. US Non-Oncology Precision Medicine Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Non-Oncology Precision Medicine Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Non-Oncology Precision Medicine Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Non-Oncology Precision Medicine Revenue Market Share, 2017-2028
Figure 16. Germany Non-Oncology Precision Medicine Revenue, (US$, Mn), 2017-2028
Figure 17. France Non-Oncology Precision Medicine Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Non-Oncology Precision Medicine Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Non-Oncology Precision Medicine Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Non-Oncology Precision Medicine Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Non-Oncology Precision Medicine Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Non-Oncology Precision Medicine Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Non-Oncology Precision Medicine Revenue Market Share, 2017-2028
Figure 24. China Non-Oncology Precision Medicine Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Non-Oncology Precision Medicine Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Non-Oncology Precision Medicine Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Non-Oncology Precision Medicine Revenue, (US$, Mn), 2017-2028
Figure 28. India Non-Oncology Precision Medicine Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Non-Oncology Precision Medicine Revenue Market Share, 2017-2028
Figure 30. Brazil Non-Oncology Precision Medicine Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Non-Oncology Precision Medicine Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Non-Oncology Precision Medicine Revenue Market Share, 2017-2028
Figure 33. Turkey Non-Oncology Precision Medicine Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Non-Oncology Precision Medicine Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Non-Oncology Precision Medicine Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Non-Oncology Precision Medicine Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Laboratories Non-Oncology Precision Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Agilent Technologies, Inc. Non-Oncology Precision Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Asuragen, Inc. Non-Oncology Precision Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Almac Group Non-Oncology Precision Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. AstraZeneca PLC Non-Oncology Precision Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bristol Myers Squibb Non-Oncology Precision Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. bioM?rieux SA. Non-Oncology Precision Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. BGI Non-Oncology Precision Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Danaher Corp. Non-Oncology Precision Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Illumina, Inc. Non-Oncology Precision Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Invitae Corporation Non-Oncology Precision Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Opko Health, Inc. Non-Oncology Precision Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
